GREM1 and cancer: As shown in Table 1 and Fig. 1c, we identified variable amounts of GREM1 expressed in fibroblast-like cells, i.e., CAFs, whereas there were no detectable levels of GREM1 in cancer-adjacent normal tissues or adjacent cancer-free breast tissues.